Secondary metastases resection after bevacizumab plus irinotecan-based chemotherapy in first-line therapy of metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
Nom du journal : Target Oncol
Année : 2016
Volume : 11
Page de départ : 83
Page de fin : 92